Knoch M, Kukule I, Müller E, Höltermann W
Abteilung für Anästhesie und Intensivtherapie, Philipps-Universität Marburg.
Anasthesiol Intensivmed Notfallmed Schmerzther. 1992 Dec;27(8):477-82. doi: 10.1055/s-2007-1000342.
This retrospective follow-up studied lung function and reconvalescence in 38 young patients without primary lung disease, who suffered from severe ARDS and survived by means of extracorporeal lung assist (ELA) treatment. Over a period of 3, 6, 9 and 12-20 months dynamic and static lung volumes and the results of X-ray and CT scan of the thorax were studied. Within the third and sixth month the forced vital capacity, FEV1, and arterial blood gases reached the lower range of normal values. Obvious relative emphysema RV/TLC was observed at the time of discharge from hospital and during the first four months. This was found to reverse during the following months. After a period of 12-20 months all patients had an abnormal diffusion capacity (TLCO) but with normal transfer coefficients (TLCO/VA). Even though ARDS did not induce obstructive changes, the diminished diffusion capacity and the slightly reduced expiratory peak flow in 25-75% of FVC (FEF 25-75) indicates slight changes in the small airways. Following up the X-ray and CT results we found extraordinary morphological restitution. Spiroergometry results showed a normal cardiopulmonary pattern for untrained individuals. 36 of the 38 patients were integrated in normal working and social life within 12-20 months.
这项回顾性随访研究了38例无原发性肺部疾病的年轻患者的肺功能和康复情况,这些患者患有严重急性呼吸窘迫综合征(ARDS),并通过体外肺辅助(ELA)治疗存活下来。在3、6、9和12至20个月的时间里,研究了动态和静态肺容量以及胸部X线和CT扫描结果。在第三个月和第六个月内,用力肺活量、第一秒用力呼气容积(FEV1)和动脉血气达到正常范围的下限。出院时及头四个月观察到明显的相对肺气肿(残气量/肺总量,RV/TLC)。在接下来的几个月里发现这种情况有所逆转。经过12至20个月后,所有患者的弥散功能(肺一氧化碳弥散量,TLCO)均异常,但转运系数(TLCO/肺泡通气量,TLCO/VA)正常。尽管ARDS未引起阻塞性改变,但25%至75%用力肺活量(FVC)时的弥散功能降低和呼气峰值流速略有降低(FEF 25-75)表明小气道有轻微改变。随访X线和CT结果发现形态学有显著恢复。运动心肺功能测试结果显示,对于未经训练的个体,心肺模式正常。38例患者中有36例在12至20个月内融入了正常的工作和社会生活。